Delveinsight

JULY 29, 2020

Today the whole world is in a search for an effective vaccine candidate against SARS-CoV-2. The vaccine appears to be the only solution to prevent coronavirus. Several pharma and biotech companies are developing and manufacturing safe and effective vaccines to fight coronavirus.

Vaccine 62

Vaccine Vaccination Clinical Trials Clinical Trials 62

XTalks

MARCH 20, 2025

The companys COVID-19 vaccine Comirnaty recorded revenues of $3.4 Pfizers COVID-19 oral treatment Paxlovid (nirmatrelvir/ritonavir) generated revenues of $727 million in the fourth quarter of 2024, reflecting a significant operational increase compared to the prior-year quarter.

Sales 59

Sales Production Drugs Development 59

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. There’s also that risk of a perceived coercion or influence. There’s sometimes a bit of a barrier,” he added.

Clinical Trials 101

Clinical Trials Clinical Trials Trials Clinical Research 101

World of DTC Marketing

JANUARY 31, 2022

Fifteen percent of those surveyed said they trust pharma companies more than before. However, on the flip side, only 16% believe pharma companies “market their products in a trustworthy manner,” and just 17% would allow pharma companies to work with their doctors to manage a chronic illness.

Pharma Companies 218

Pharma Companies Life Science Vaccination Vaccine 218

Pharmaceutical Technology

MAY 2, 2023

ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B funding round. This software-as-a-service (SaaS) platform is also used by life science brands to launch their drugs, therapeutics and vaccines in the markets, using data-driven solution.

Life Science 147

Life Science Branding Pharma Companies Production 147

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

Life Science 98

Life Science RNA Vaccine Vaccination 98

pharmaphorum

NOVEMBER 23, 2022

A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My We looked at the areas of rare diseases, cell and gene therapy, vaccines – loads of different perspectives. Innovative offerings around market access. Smart reviewing: utilising AI and ML.

Life Science 98

Life Science Marketing Medicine Production 98

pharmaphorum

APRIL 7, 2021

With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. He notes that it already has 21 partnerships with pharma companies and will aim to keep more product rights than it did in the past. Role models.

Antibody 91

Antibody Life Science Development Drugs 91

XTalks

FEBRUARY 16, 2022

The editorial team discussed the high costs associated with orphan drugs and how both governments and pharma companies must work together to make them accessible to patients. The team also talked about a digital risk report that revealed the existence of significant cybersecurity vulnerabilities among the world’s top pharma companies.

Life Science 52

Life Science Gene Therapy Drugs Pharma Companies 52

pharmaphorum

MARCH 2, 2021

UK chancellor Rishi Sunak has been urged to recognise the leading role that pharma companies are playing in the economy in this week’s budget. According to a report last month from the BioIndustry Association, covering life sciences and biotech, there was a record $2.8

Life Science 105

Life Science Vaccination Vaccine Pharma Companies 105

XTalks

OCTOBER 4, 2023

In my current role, I have country-level responsibility for AstraZeneca’s entire portfolio, including cardiovascular, respiratory, vaccines and oncology. Considering how challenging market access can be for large, established pharma companies, what does it look like on the small biotech level?

Marketing 105

Marketing Development Drugs Gene Therapy 105

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. Pfizer is also the co-developer of what is arguably the most successful COVID-19 vaccine rollout.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

XTalks

MAY 25, 2021

Biosimilar and interchangeable products can expand treatment options and lower drug and healthcare costs by offering a cheaper alternative with the same effectiveness; essentially a non-branded version of a biologic such as monoclonal antibodies, proteins and vaccines. million in 2019, according to Fortune Business Insights.

Production 98

Production Drugs Marketing Sales 98

XTalks

FEBRUARY 9, 2022

Findings from an analysis conducted by Constella Intelligence , a digital risk protection company, show widespread cybersecurity vulnerabilities that are costing pharma companies significantly. The report includes information on breaches, exposures and leaks in the pharma sphere. Pharma Cybersecurity and Cyber Attacks.

Pharma Companies 98

Pharma Companies Insulin Packaging Packaging 98

XTalks

OCTOBER 22, 2020

However, during the last months, due to COVID-19, we have observed how pharmaceutical companies have progressed very quickly through all the clinical development phases and different companies have already reached the clinical Phase III.

Manufacturing 98

Manufacturing Development Production Gene Therapy 98

pharmaphorum

DECEMBER 23, 2020

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. Pharma companies have also made headway in rare diseases as several pipeline projects came to fruition. Rare disease progress.

Marketing 96

Marketing Gene Gene Silencing Drugs 96

pharmaphorum

MARCH 9, 2021

Regeneron and Eli Lilly have already got antibody therapies on the market following emergency approvals by regulators including the FDA but pharma companies are beginning to focus on the threat posed by emerging variants.

Antibody 98

Antibody Life Science Scientist Development 98

XTalks

AUGUST 18, 2020

These unique and unified efforts may almost be as unprecedented as the modern-day pandemic itself. They have been a positive element during these challenging times and could serve as models for future interdisciplinary partnerships.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

pharmaphorum

SEPTEMBER 7, 2022

Pharma has a great opportunity ahead of it when it comes to conducting representative clinical trials. The industry’s application of mRNA techniques during the pandemic led to the fastest vaccine development in history. Whilst this is an early area of research, pharma can turn the dial now. About the author.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Genetics 98

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

XTalks

AUGUST 24, 2021

In November 2020 during the third quarter, Berkshire spent billions of dollars on shares of four US pharma giants: AbbVie, Bristol Myers Squibb, Merck & Co. This was likely fueled by the flurry of development happening in the pharma space with COVID-19 vaccines and therapeutics. and Pfizer.

Drugs 98

Drugs Pharma Companies Vaccine Vaccination 98

pharmaphorum

NOVEMBER 6, 2020

The sharing of knowledge has already been critical in the industry’s collaborative efforts to expedite a COVID-19 vaccine, and Nikitczuk believes that this open approach should extend beyond research into the software and data tools pharma uses every day. About the interviewees.

Life Science 59

Life Science Pharma Companies Production Development 59

pharmaphorum

MAY 27, 2022

There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials. Underrepresentation is multifactorial, so concerted efforts from life science companies are required to address inequitable healthcare. What comes next?

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

XTalks

MAY 23, 2024

Takeda Pharmaceutical (Rank 86) Takeda Pharmaceutical, based in Japan, is dedicated to discovering and providing life-changing treatments across key therapeutic and business domains, encompassing gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.

Life Science 52

Life Science Medicine Manufacturing Engineer 52

pharmaphorum

FEBRUARY 25, 2022

The past two years have shone a spotlight on the UK life sciences industry. Pharma companies are now household names, having been thrust into the public’s consciousness after dominating the headlines through the pandemic. An industry that will forever play a greater role in our everyday lives. About the author.

Life Science 98

Life Science Vaccination Vaccine Pharmacy 98

Pharmaceutical Technology

MAY 26, 2023

Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines. The British company’s expanded facilities boasts of 11 suites, including two class B filling suites with class A filling cabinets, warehousing and quality control laboratory capability.

DNA 130

DNA Manufacturing Gene Gene Therapy 130

XTalks

JUNE 25, 2024

In the past two years, the industry has faced considerable challenges due to a constrained financing environment, forcing many emerging and early-stage biotech companies to restructure their operations, merge with other companies or narrow their research and development (R&D) efforts by shelving certain assets. billion in 2023.

Pharma Companies 52

Pharma Companies Production FDA Approval Vaccination 52

pharmaphorum

DECEMBER 16, 2020

We’ve got so many great life science assets in the UK, but there are still some gaps – manufacturing capacity being one of them.”. “We We had companies collaborating to develop laboratories. We had companies sourcing consumables for testing machines. The road to a vaccine. A collaborative future.

Vaccine 122

Vaccine Vaccination Life Science In-Vitro 122

XTalks

MAY 29, 2024

Here, we will deep-dive into the top five fastest growing pharma and biotech companies in 2024, showcasing their innovative strategies and inspiring achievements. Pfizer (Overall Rank 268) Leading the list is one of the most renowned pharma companies in the world: Pfizer.

Medicine 52

Medicine Marketing FDA Approval Development 52

pharmaphorum

APRIL 5, 2022

That culture clash makes it hard to innovate the world of pharma at scale and with any rapidity. And investment in pharma followed suit: pharma companies were looked at as stable assets — reliable but unlikely to balloon in value like a tech company might. Start-ups move fast and break things.

Pharma R&D 52

Pharma R&D Life Science Pharma Companies Clinical Trials 52

XTalks

APRIL 16, 2024

Backlash against celebrities for partnering with pharma companies isn’t new. Singer Pink also received some heat after she teamed up with Pfizer to back the company’s COVID-19 vaccine. Football star Travis Kelce was recently slammed for his partnership with Pfizer to promote the flu shot and COVID-19 booster.

Drugs 52

Drugs Pharma Companies Doctors Doctor 52

Pharmaceutical Technology

APRIL 24, 2023

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. With new drugs on the market, companies are now looking for ways to manufacture recently approved biologics, and countries are racing to claim their corner – or maintain their decades-old market share.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

pharmaphorum

APRIL 19, 2021

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. But Dix has also been leading the UK’s Vaccine Taskforce, after taking over the hot seat in December following the departure of Kate Bingham.

Vaccination 98

Vaccination Vaccine Life Science Antibody 98

pharmaphorum

MARCH 22, 2021

For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. It is not only COVID-19 vaccines and therapeutics that benefit from a more regionalised approach. About the author. Dr Subir K.

Manufacturing 122

Manufacturing Marketing Vaccination Vaccine 122

pharmaphorum

JANUARY 6, 2022

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead. Outsourcing services are on of the pillars of Merck’s business, delivered via its process solutions unit, part of the group’s life sciences division.

Vaccination 98

Vaccination Vaccine Manufacturing Life Science 98

XTalks

DECEMBER 13, 2023

These companies were identified through The Americas’ Fastest-Growing Companies 2023 list by the Financial Times. In 2023, Moderna is poised to achieve sales figures ranging from $6 billion to $8 billion, contingent on the prevailing COVID-19 vaccination rates in the US. vaccine, mRNA-1273.815.

Genetics 111

Genetics Vaccination Vaccine DNA 111

pharmaphorum

DECEMBER 15, 2022

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the NHS Innovation and Life Sciences Commission Report launch took place at One Great George Street, Westminster, on 12th December 2022. The UK as a powerhouse of research.

Life Science 97

Life Science Medicine Clinical Trials Clinical Trials 97